Status:
COMPLETED
Neurodevelopmental Disorders in Children With Congenital Heart Disease
Lead Sponsor:
University Hospital, Lille
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
6-66 years
Brief Summary
Children with congenital heart disease are at risk for neurodevelopmental disorders, these disorders impacting their quality of life and their integration into society. The aim of this study is to de...
Detailed Description
Are selected children with "significant" congenital heart disease (aged from 6 to 66 months) in "Nord-Pas-De-Calais" fulfilling inclusion criteria. A reliable and valid questionnaire used to screen de...
Eligibility Criteria
Inclusion
- Children aged 6 to 66 months at the time of study
- living in region "Nord-Pas-De-Calais"
- with " significant" congenital heart disease (= complex congenital heart diseases operated or not, simple or moderate congenital heart disease who had cardiac surgery)
- Followed by the Pediatric Cardiology Department of Lille University Hospital, or patients having a cardiopediatric follow-up outside Lille University Hospital but having been taken in charge at the University Hospital of Lille for any reason (cardiac or not)
Exclusion
- Children :
- lost to sight
- Deceased
- with congenital heart disease, living in Nord-Pas-de-Calais but never having been taken in charge at Lille University Hospital
- with mild or moderate congenital heart disease not having undergone surgery or having only undergone cardiac catheterization
- with cardiac surgery not performed in the Centers of Jacques CARTIER and Marie LANNNELONGUE
Key Trial Info
Start Date :
December 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2018
Estimated Enrollment :
233 Patients enrolled
Trial Details
Trial ID
NCT03360370
Start Date
December 6 2017
End Date
June 6 2018
Last Update
August 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Jeanne de Flandres, CHU
Lille, France